HHS sued over delay in drug pricing transparency regulations

(By Kelly Gooch for Becker’s Hospital Review)

The American Hospital Association and six other health organizations  have sued HHS for delaying the implementation of rules that would force drug companies to be open about their pricing and punish them for overcharging participants in a federal drug discount program. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.